Knockdown of the long noncoding RNA XIST suppresses glioma progression by upregulating miR-204-5p
Conclusion: Our results provide evidence that XIST, miR-204-5p and Bcl-2 form a regulatory axis that controls glioma progression and can serve as a potential therapeutic target for glioma.
Source: Journal of Cancer - Category: Cancer & Oncology Authors: Jun Shen, Jianhua Xiong, Xuefei Shao, Hao Cheng, Xinyun Fang, Yongkang Sun, Guangfu Di, Jie Mao, Xiaochun Jiang Tags: Research Paper Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Genetics | Glioma | Neurology | Study